HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
453studies shown
Showing 241-252 of 453
Other study type icon
RecruitingNCT06651112

The ATP Project (Antipsychotic-TEP-Psychosis)

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Sherbrooke
SchizophreniaObservational studyAges 18–35
Countries
Canada
Sponsor
Université de Sherbrooke
Other study type icon
RecruitingNCT05763966

Uppsala Psychosis Cohort

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

In Uppsala
SchizophreniaObservational studyAges 18–40
Countries
Sweden
Sponsor
Uppsala University
Drug study icon
RecruitingEUCTR 2021-000350-26

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Kazanlik
SchizophreniaHistorical research record
Countries
Bulgaria, Poland, Romania, + 2 others
Sponsor
Oryzon Genomics, S.A.
Drug study icon
RecruitingEUCTR 2017-001170-42

An adaptive Phase II/III, Double-Blind, Randomized, Placebo-controlled, Two-Part, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase In...

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

Multiple locations, including Gdańsk
SchizophreniaHistorical research record
Countries
Poland
Sponsor
SyneuRx International (Taiwan) Corp
Drug study icon
RecruitingEUCTR 2021-001333-38

Cognitive effects of adjuntive Vortioxetine in early Schizophrenia

What is this study about?

A short description of this study's objective has not yet been verified by HopeStage.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

In Sevilla
SchizophreniaHistorical research record
Countries
Spain
Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.